Healthstream (HSTM) Cash from Financing Activities (2016 - 2026)
Healthstream has reported Cash from Financing Activities over the past 16 years, most recently at -$7.2 million for Q4 2025.
- Quarterly Cash from Financing Activities fell 601.26% to -$7.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$36.3 million through Dec 2025, down 703.08% year-over-year, with the annual reading at -$36.3 million for FY2025, 703.08% down from the prior year.
- Cash from Financing Activities was -$7.2 million for Q4 2025 at Healthstream, up from -$7.9 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at -$20000.0 in Q3 2022 and troughed at -$20.2 million in Q1 2022.
- The 5-year median for Cash from Financing Activities is -$1.7 million (2024), against an average of -$4.4 million.
- Year-over-year, Cash from Financing Activities skyrocketed 99.18% in 2022 and then crashed 17502.13% in 2023.
- A 5-year view of Cash from Financing Activities shows it stood at -$5.7 million in 2021, then skyrocketed by 99.18% to -$47000.0 in 2022, then crashed by 17502.13% to -$8.3 million in 2023, then soared by 87.51% to -$1.0 million in 2024, then crashed by 601.26% to -$7.2 million in 2025.
- Per Business Quant, the three most recent readings for HSTM's Cash from Financing Activities are -$7.2 million (Q4 2025), -$7.9 million (Q3 2025), and -$19.1 million (Q2 2025).